This HND piece takes a look at addiction drug Vivitrol, and how it compares to methadone and buprenorphine. Many have complained that the makers of Vivitrol have marketed almost exclusively to the criminal justice community, and have glossed over potential problems with the drug.
Now, the FDA has gone after Alkermes, the manufacturer, for misleading advertising. Let's just say that the marketing of Vivitrol is a bit light in the ethics department.
Read the complete article.